Purchase Short-Term Access
Insulin secretagogues were associated with increased mortality compared with metformin in type 2 diabetes
Gabriela Prutsky, MD; Juan Pablo Domecq, MD; Apostolos Tsapas, MD, PhD
Annals of Internal Medicine 2012;156:JC1-7.
doi:10.7326/0003-4819-156-2-201201170-02007
Purchase Online access to this article for 24 hours
